Ginkgo Bioworks Holdings, INC DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
NYSE
Ginkgo Bioworks Holdings, Inc. has filed a definitive proxy statement with the SEC.
NYSE
Ginkgo Bioworks will hold its 2025 Annual Meeting of Shareholders virtually on June 12, 2025, to vote on director elections, ratification of the accounting firm, and executive compensation.
NYSE
DEFA14A: Ginkgo Bioworks Corrects Voting Standard for Reverse Stock Split Proposal Ahead of Special Meeting
Ginkgo Bioworks issues a supplement to its proxy statement to correct an error in the description of the voting standard for the reverse stock split proposal.
NYSE
Ginkgo Bioworks is asking shareholders to approve a reverse stock split, officer exculpation, and charter updates at a special meeting on August 14, 2024.
NYSE
Ginkgo Bioworks nominates Myrtle Potter and Ross Fubini as independent directors while Marijn Dekkers and Reshma Kewalramani will retire from the board at the upcoming annual meeting on June 13, 2024.
NYSE
Ginkgo Bioworks will hold its 2024 Annual Meeting of Shareholders virtually on June 13, 2024, to vote on director elections, ratification of the independent auditor, and executive compensation.